Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.

CONCLUSION: The recombinant virus rSNHA-△200 can be used as a potential broad-spectrum vaccine against H9N2 avian influenza.
PMID: 30797637 [PubMed - as supplied by publisher]

Source: Vaccine - February 20, 2019 Category: Allergy & Immunology Authors: Wang Z, Li Z, Su X, Qiao Y, Fan W, Li H, Shi B, Qin T, Chen S, Peng D, Liu X Tags: Vaccine Source Type: research